TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet
- PMID: 15879087
- DOI: 10.4049/jimmunol.174.10.5950
TGF-beta 1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4+ T cells at priming and at recall: differential involvement of Stat4 and T-bet
Abstract
TGF-beta1 plays a critical role in restraining pathogenic Th1 autoimmune responses in vivo, but the mechanisms that mediate TGF-beta1's suppressive effects on CD4(+) T cell expression of IFN-gamma expression remain incompletely understood. To evaluate mechanisms by which TGF-beta1 inhibits IFN-gamma expression in CD4(+) T cells, we primed naive wild-type murine BALB/c CD4(+) T cells in vitro under Th1 development conditions in the presence or the absence of added TGF-beta1. We found that the presence of TGF-beta1 during priming of CD4(+) T cells suppressed both IFN-gamma expression during priming as well as the development of Th1 effector cells expressing IFN-gamma at a recall stimulation. TGF-beta1 inhibited the development of IFN-gamma-expressing cells in a dose-dependent fashion and in the absence of APC, indicating that TGF-beta1 can inhibit Th1 development by acting directly on the CD4(+) T cell. During priming, TGF-beta1 strongly inhibited the expression of both T-bet (T box expressed in T cells) and Stat4. We evaluated the importance of these two molecules in the suppression of IFN-gamma expression at the two phases of Th1 responses. Enforced expression of T-bet by retrovirus prevented TGF-beta1's inhibition of Th1 development, but did not prevent TGF-beta1's inhibition of IFN-gamma expression at priming. Conversely, enforced expression of Stat4 partly prevented TGF-beta1's inhibition of IFN-gamma expression during priming, but did not prevent TGF-beta1's inhibition of Th1 development. These data show that TGF-beta1 uses distinct mechanisms to inhibit IFN-gamma expression in CD4(+) T cells at priming and at recall.
Similar articles
-
TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1.J Immunol. 2005 Nov 1;175(9):5666-74. doi: 10.4049/jimmunol.175.9.5666. J Immunol. 2005. PMID: 16237056
-
Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3.J Immunol. 2005 Feb 15;174(4):2071-83. doi: 10.4049/jimmunol.174.4.2071. J Immunol. 2005. PMID: 15699137
-
Transforming growth factor-beta1 enhances the interferon-gamma-dependent, interleukin-12-independent pathway of T helper 1 cell differentiation.Immunology. 2005 Apr;114(4):484-92. doi: 10.1111/j.1365-2567.2005.02115.x. Immunology. 2005. PMID: 15804285 Free PMC article.
-
Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation.Immunol Today. 1997 Feb;18(2):61-4. doi: 10.1016/s0167-5699(97)01000-1. Immunol Today. 1997. PMID: 9057354 Review.
-
Type I interferons and T helper development.Immunol Today. 2000 Oct;21(10):484-9. doi: 10.1016/s0167-5699(00)01710-2. Immunol Today. 2000. PMID: 11071526 Review. No abstract available.
Cited by
-
Reduced estrogen signaling contributes to bone loss and cardiac dysfunction in interleukin-10 knockout mice.Physiol Rep. 2024 Jan;12(1):e15914. doi: 10.14814/phy2.15914. Physiol Rep. 2024. PMID: 38217044 Free PMC article.
-
Regulation of T cells by myeloid-derived suppressor cells: emerging immunosuppressor in lung cancer.Discov Oncol. 2023 Oct 19;14(1):185. doi: 10.1007/s12672-023-00793-1. Discov Oncol. 2023. PMID: 37857728 Free PMC article. Review.
-
TGF-β in correlation with tumor progression, immunosuppression and targeted therapy in colorectal cancer.Med Oncol. 2023 Oct 19;40(11):335. doi: 10.1007/s12032-023-02204-5. Med Oncol. 2023. PMID: 37855975 Review.
-
Interplay between signal transducers and activators of transcription (STAT) proteins and cancer: involvement, therapeutic and prognostic perspective.Clin Exp Med. 2023 Dec;23(8):4323-4339. doi: 10.1007/s10238-023-01198-8. Epub 2023 Sep 29. Clin Exp Med. 2023. PMID: 37775649 Review.
-
The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and Tumorigenesis.Front Immunol. 2022 May 26;13:891268. doi: 10.3389/fimmu.2022.891268. eCollection 2022. Front Immunol. 2022. PMID: 35720407 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
